Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

294 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validation of the Polish version of the EORTC QLQ-OV28 module for the assessment of health-related quality of life in women with ovarian cancer.
Paradowski J, Tomaszewski KA, Bereza K, Tomaszewska IM, Pasternak A, Paradowska D, Szczęsny E, Golec EB, Greimel ER, Bottomley A. Paradowski J, et al. Among authors: bottomley a. Expert Rev Pharmacoecon Outcomes Res. 2014 Feb;14(1):157-63. doi: 10.1586/14737167.2014.868309. Epub 2013 Dec 20. Expert Rev Pharmacoecon Outcomes Res. 2014. PMID: 24354727
Differential item functioning (DIF) in the EORTC QLQ-C30: a comparison of baseline, on-treatment and off-treatment data.
Scott NW, Fayers PM, Aaronson NK, Bottomley A, de Graeff A, Groenvold M, Gundy C, Koller M, Petersen MA, Sprangers MA; EORTC Quality of Life Group and the Quality of Life Cross-Cultural Meta-Analysis Group. Scott NW, et al. Among authors: bottomley a. Qual Life Res. 2009 Apr;18(3):381-8. doi: 10.1007/s11136-009-9453-7. Epub 2009 Feb 27. Qual Life Res. 2009. PMID: 19247808
Health-related quality of life and cancer.
Bottomley A. Bottomley A. Expert Rev Pharmacoecon Outcomes Res. 2009 Feb;9(1):9-11. doi: 10.1586/14737167.9.1.9. Expert Rev Pharmacoecon Outcomes Res. 2009. PMID: 19371172 No abstract available.
Trends in translation requests and arising issues regarding cultural adaptation.
Kuliś D, Arnott M, Greimel ER, Bottomley A, Koller M; European Organisation for Research and Treatment of Cancer Quality of Life Group. Kuliś D, et al. Among authors: bottomley a. Expert Rev Pharmacoecon Outcomes Res. 2011 Jun;11(3):307-14. doi: 10.1586/erp.11.27. Expert Rev Pharmacoecon Outcomes Res. 2011. PMID: 21671700 Review.
Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data.
Martinelli F, Quinten C, Maringwa JT, Coens C, Vercauteren J, Cleeland CS, Flechtner H, Gotay C, Greimel E, King M, Mendoza T, Osoba D, Reeve BB, Ringash J, Koch JS, Shi Q, Taphoorn MJ, Weis J, Bottomley A; European Organisation for Research and Treatment of Cancer Clinical Groups. Martinelli F, et al. Among authors: bottomley a. Expert Rev Pharmacoecon Outcomes Res. 2011 Oct;11(5):587-99. doi: 10.1586/erp.11.51. Expert Rev Pharmacoecon Outcomes Res. 2011. PMID: 21958103
Validation of the Polish version of the EORTC QLQ-BM22 module for the assessment of health-related quality of life in patients with bone metastases.
Püsküllüoğlu M, Tomaszewski KA, Bottomley A, Holden L, Tomaszewska IM, Głowacki R, Bereza K, Golec EB, Chow E, Krzemieniecki K. Püsküllüoğlu M, et al. Among authors: bottomley a. Qual Life Res. 2014 Mar;23(2):527-32. doi: 10.1007/s11136-013-0486-6. Epub 2013 Aug 3. Qual Life Res. 2014. PMID: 23912854
The reliability and validity of the Iranian version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with Bone Metastases: the EORTC QLQ-BM22.
Yekaninejad MS, Ahmadzadeh A, Mosavi SH, Saffari M, Pakpour AH, Tolooei F, Chow E, Bottomley A. Yekaninejad MS, et al. Among authors: bottomley a. Expert Rev Pharmacoecon Outcomes Res. 2014 Feb;14(1):147-56. doi: 10.1586/14737167.2014.864559. Epub 2013 Dec 13. Expert Rev Pharmacoecon Outcomes Res. 2014. PMID: 24328844
International Psychometric Validation of an EORTC Quality of Life Module Measuring Cancer Related Fatigue (EORTC QLQ-FA12).
Weis J, Tomaszewski KA, Hammerlid E, Ignacio Arraras J, Conroy T, Lanceley A, Schmidt H, Wirtz M, Singer S, Pinto M, Alm El-Din M, Compter I, Holzner B, Hofmeister D, Chie WC, Czeladzki M, Harle A, Jones L, Ritter S, Flechtner HH, Bottomley A; EORTC Quality of Life Group. Weis J, et al. Among authors: bottomley a. J Natl Cancer Inst. 2017 May 1;109(5). doi: 10.1093/jnci/djw273. J Natl Cancer Inst. 2017. PMID: 28376231 Free article.
294 results